January 2021 - Swiss Vaccine Research Institute

Fenwick, C., Croxatto, A., Coste, A. T., Pojer, F., Andre, C., Pellaton, C., Farina, A., Campos, J., Hacker, D., Lau, K., Bosch, B. J., Gonseth Nussle, S., Bochud, M., D’Acremont, V., Trono, D., Greub, G., and Pantaleo, G.

Jan 13, 2021 | Publications

Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies

Volk, V., Theobald, S. J., Danisch, S., Khailaie, S., Kalbarczyk, M., Schneider, A., Bialek-Waldmann, J., Kronke, N., Deng, Y., Eiz-Vesper, B., Dragon, A. C., von Kaisenberg, C., Lienenklaus, S., Bleich, A., Keck, J., Meyer-Hermann, M., Klawonn, F., Hammerschmidt, W., Delecluse, H. J., Munz, C., Feuerhake, F., and Stripecke, R.

Jan 12, 2021 | Publications

PD-1 Blockade Aggravates Epstein-Barr Virus+ Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4+ T Cell Dysregulations

Zdimerova, H., Murer, A., Engelmann, C., Raykova, A., Deng, Y., Gujer, C., Ruhl, J., McHugh, D., Caduff, N., Naghavian, R., Pezzino, G., Capaul, R., Zbinden, A., Ferlazzo, G., Lunemann, J. D., Martin, R., Chatterjee, B., and Munz, C.

Jan 1, 2021 | Publications

Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15

Fenwick, C., Croxatto, A., Coste, A. T., Pojer, F., Andre, C., Pellaton, C., Farina, A., Campos, J., Hacker, D., Lau, K., Bosch, B. J., Gonseth Nussle, S., Bochud, M., D’Acremont, V., Trono, D., Greub, G., and Pantaleo, G.

Zdimerova, H., Murer, A., Engelmann, C., Raykova, A., Deng, Y., Gujer, C., Ruhl, J., McHugh, D., Caduff, N., Naghavian, R., Pezzino, G., Capaul, R., Zbinden, A., Ferlazzo, G., Lunemann, J. D., Martin, R., Chatterjee, B., and Munz, C.

Archives